Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2011-06-20 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, Shenguan Holdings (Group) Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share issues (bonus shares) and repurchases, referencing compliance with the Listing Rules of the Hong Kong Stock Exchange. The content focuses on capital changes and share repurchase disclosures rather than financial performance, management discussion, or regulatory certifications. This matches the description of a Share Issue/Capital Change filing, which covers announcements regarding new share issues, stock splits, or other capital changes. The document length (6447 characters) and detailed data support it being the actual disclosure rather than a mere announcement of a report. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2011-06-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2011
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 May 2011, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. It is not an annual or interim report, earnings release, or management report. Given the detailed nature of share capital movements and the regulatory submission context, this fits best under 'Share Issue/Capital Change' (SHA). The document length is substantial and contains detailed data, confirming it is the report itself, not just an announcement. Therefore, the classification is SHA with high confidence.
2011-06-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2011
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30 April 2011, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, which fits the category of Share Issue/Capital Change (SHA). The document length is substantial (over 14,000 characters), indicating it is the report itself, not just an announcement of a report publication.
2011-05-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2011
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 March 2011. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on changes in the company's share capital structure and related securities movements. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting share capital movements to the Hong Kong Exchanges and Clearing Limited. This type of document fits the category of Share Issue/Capital Change (SHA), as it reports on changes in share capital and related securities.
2011-04-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2011
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28 February 2011. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements to the Hong Kong Exchanges and Clearing Limited. This type of document fits the category of Capital/Financing Update (CAP) as it provides updates on the company's capital structure changes and share movements.
2011-03-04 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Uni-Bio Science Group Limited regarding the results of independent external business valuers' reports on past acquisitions and the status of trading suspension on the company's shares. It references ongoing discussions with the Stock Exchange about resumption of trading and previous announcements. The document is relatively short (2909 characters) and does not contain detailed financial statements or comprehensive report data. It is an announcement about valuation reports and trading suspension status rather than the reports themselves. Therefore, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2011-02-08 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.